(b).

	POSG						PCG
	A carrier			Noncarrier			A carrier			Noncarrier
	Baseline	T1	p	Baseline	T1	p	Baseline	T1	p	Baseline	T1	p
Total BUT score	42.16 ± 41.46	47.42 ± 43.11	0.787	40.65 ± 22.89	35.83 ± 40.40	0.565	41.67 ± 37.64	45.09 ± 45.89	0.521	49.67 ± 25.86	43.33 ± 3.51	0.258
BUT GSI score	1.45 ± 1.22	1.39 ± 1.27	0.341	0.90 ± 0.67	0.91 ± 1.19	0.566	0.76 ± 1.22	1.33 ± 1.35	0.128	0.78 ± 0.17	0.83 ± 0.10	0.162
Total SCL-90R score	78.53 ± 58.81	74.36 ± 58.22	0.140	68.12 ± 43.18	59.60 ± 62.56	0.374	62.67 ± 40.60	63.54 ± 58.76	0.296	63.30 ± 38.72	60.33 ± 42.52	0.624
SCL-90R GSI score	0.87 ± 0.65	0.83 ± 0.65	0.302	0.53 ± 0.37	0.64 ± 0.69	0.064	0.70 ± 0.23	0.82 ± 0.65	0.652	0.67 ± 0.10	0.90 ± 0.33	0.136
Hamilton score	13.03 ± 8.00	9.33 ± 7.42	0.001	8.50 ± 6.63	6.07 ± 6.61	0.152	14.38 ± 4.37	14.13 ± 4.26	0.351	7.67 ± 5.75	7.33 ± 5.28	0.363

Results are expressed in mean ± standard deviation. t-test was used for all parameters. Significant values are for p < 0.05. POSG: probiotic oral suspension group; PCG: placebo control group; BUT: Body Uneasiness Test; SCL90R: Symptom Checklist-Revised; HAM-A: Hamilton Anxiety Rating Scale; BUT GSI: Body Uneasiness Test Global Severity Index; SCL90R GSI: Symptom Checklist-Revised Global Severity Index.